Matches in Wikidata for { <http://www.wikidata.org/entity/Q94424014> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q94424014 description "article scientifique publié en 2019" @default.
- Q94424014 description "wetenschappelijk artikel" @default.
- Q94424014 description "наукова стаття" @default.
- Q94424014 name "MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome" @default.
- Q94424014 name "MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome" @default.
- Q94424014 type Item @default.
- Q94424014 label "MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome" @default.
- Q94424014 label "MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome" @default.
- Q94424014 prefLabel "MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome" @default.
- Q94424014 prefLabel "MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome" @default.
- Q94424014 P1433 Q94424014-05BC6C02-5404-4BD9-A62B-79268C17C2DB @default.
- Q94424014 P1476 Q94424014-C3598F17-8D48-4D49-BBDD-1DC51DB4D9E9 @default.
- Q94424014 P2093 Q94424014-2F2B51B9-51BB-497C-BD39-5490D62FD76B @default.
- Q94424014 P2093 Q94424014-3FCA7FAE-2622-497F-8428-B7352BAFADA6 @default.
- Q94424014 P2093 Q94424014-65104BF8-C41F-4718-AB1A-B040F252B75A @default.
- Q94424014 P2093 Q94424014-9CD07AFC-BF12-4220-B1E1-267D14AC3074 @default.
- Q94424014 P2093 Q94424014-F10CED2D-FE0A-4E6F-9646-0AE4145D5BF2 @default.
- Q94424014 P275 Q94424014-9809c448-0394-4d35-afa5-2c8385c0f8c1 @default.
- Q94424014 P31 Q94424014-E4658579-6C32-45AD-B47A-740AF3E12C6C @default.
- Q94424014 P356 Q94424014-1C35D02F-AF7F-46A4-BC61-8C32C5EDF023 @default.
- Q94424014 P407 Q94424014-5A4788F2-81D7-4B43-BC42-195681DAB7F0 @default.
- Q94424014 P433 Q94424014-92597EEE-C4B4-49D8-91A3-2B8A9E5EFDF2 @default.
- Q94424014 P478 Q94424014-3B7767C8-5F65-4777-973F-190F8547B1C8 @default.
- Q94424014 P577 Q94424014-0C4ABF39-87F1-4A4D-89C2-E1095D389F88 @default.
- Q94424014 P6216 Q94424014-263b5260-67b6-4f5f-8a23-4f49fada04d9 @default.
- Q94424014 P921 Q94424014-B436153B-9818-43E4-B88B-21A3F04B1312 @default.
- Q94424014 P932 Q94424014-F09569D7-4C0B-458E-A9CE-AAB35B5C4217 @default.
- Q94424014 P356 JS.2019-MON-102 @default.
- Q94424014 P1433 Q50817780 @default.
- Q94424014 P1476 "MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome" @default.
- Q94424014 P2093 "Andrew Spencer" @default.
- Q94424014 P2093 "Didier Cade" @default.
- Q94424014 P2093 "Jean-Paul Briffaux" @default.
- Q94424014 P2093 "Soraya Allas" @default.
- Q94424014 P2093 "Stephane Milano" @default.
- Q94424014 P275 Q24082749 @default.
- Q94424014 P31 Q13442814 @default.
- Q94424014 P356 "10.1210/JS.2019-MON-102" @default.
- Q94424014 P407 Q1860 @default.
- Q94424014 P433 "Suppl 1" @default.
- Q94424014 P478 "3" @default.
- Q94424014 P577 "2019-04-30T00:00:00Z" @default.
- Q94424014 P6216 Q50423863 @default.
- Q94424014 P921 Q594013 @default.
- Q94424014 P932 "6550718" @default.